Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TOSCA: Risperidone and Stimulant in Aggressive Children
NCT00796302Phase 4Completed
- Start
- Aug 2008
- Primary completion
- Nov 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of risperidone in attention deficit hyperactivity disorder (ADHD), conduct disorder (CD), oppositional defiant disorder (ODD). Started Aug 2008; status: completed.
02
Drugs
risperidone
03
Conditions
attention deficit hyperactivity disorder (ADHD)conduct disorder (CD)oppositional defiant disorder (ODD)
Beyond the preview
Go deeper on NCT00796302.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00796302.